Regulating developments in embryonic stem cell research in Africa: a third person's perspective.
Among the many advances in modern biotechnology, embryonic stem (ES) cell research has raised perhaps the most intense debate over the ethical, legal and policy issues involved. This debate has centred inter alia on the lives and well-being of the donors or participants in clinical trials, the presumed lives of embryos, the possibility of reproductive cloning, and government funding, among others. These ethical, legal and policy issues tend to overlap and cut across all strata of society, with opponents of the research calling for prohibition and proponents calling for promotion. One important question is whether African countries should regulate to limit or promote developments in ES cell research. This article argues that, in view of the dynamism of modern biotechnology, African countries should regulate in such a way as to maximise the benefits while minimising the disadvantages associated with the research.
Amechi
Emeka Polycarp
EP
University of the Witwatersand, Johannesburg, South Africa.
D000349:Africa; D033041:Embryo Research / Q000941:ethics* / Q000331:legislation & jurisprudence*; D053595:Embryonic Stem Cells; D006291:Health Policy; D006801:Humans